Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc.verified

PSTX

Price:

$9.5

Market Cap:

$925.93M

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD...[Read more]

Industry

Biotechnology

IPO Date

2020-07-10

Stock Exchange

NASDAQ

Ticker

PSTX

The PE Ratio as of November 2025 (TTM) for Poseida Therapeutics, Inc. (PSTX) is -15.08

According to Poseida Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -15.08. This represents a change of 1.08% compared to the average of -1.28 of the last 4 quarters.

Poseida Therapeutics, Inc. (PSTX) Historical PE Ratio (quarterly & annually)

How has PSTX PE Ratio performed in the past?

The mean historical PE Ratio of Poseida Therapeutics, Inc. over the last ten years is 12.49. The current -15.08 PE Ratio has changed -12172.51% with respect to the historical average. Over the past ten years (40 quarters), PSTX's PE Ratio was at its highest in in the December 2021 quarter at 72.44K. The PE Ratio was at its lowest in in the December 2020 quarter at -4690.67.

Quarterly (TTM)
Annual

Average

12.49

Median

-6.27

Minimum

-199.02

Maximum

261.23

Poseida Therapeutics, Inc. (PSTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Poseida Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = 261.23

Minimum Annual Increase = -4067.76%

Minimum Annual PE Ratio = -199.02

Quarterly (TTM)
Annual
YearPE RatioChange
2023-2.46-58.77%
2022-5.96-106.19%
202196.15-63.19%
2020261.23-4067.76%
2019-6.58-46.99%
2018-12.42-59.96%
2017-31.02-84.41%

Poseida Therapeutics, Inc. (PSTX) Average PE Ratio

How has PSTX PE Ratio performed in the past?

The current PE Ratio of Poseida Therapeutics, Inc. (PSTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

29.25

5-year avg

68.48

10-year avg

12.49

Poseida Therapeutics, Inc. (PSTX) PE Ratio vs. Peers

How is PSTX’s PE Ratio compared to its peers?

Poseida Therapeutics, Inc.’s PE Ratio is less than Gracell Biotechnologies Inc. (-1.62), less than Harpoon Therapeutics, Inc. (-1.14), less than Albireo Pharma, Inc. (-5.61), less than Verve Therapeutics, Inc. (-5.46), less than Intercept Pharmaceuticals, Inc. (5.58), greater than Crescent Biopharma, Inc. (-38.39), less than Chimerix, Inc. (-11.59), less than VectivBio Holding AG (-7.94), greater than Avid Bioservices, Inc. (-34.76), less than Icosavax, Inc. (-6.88),

Build a custom stock screener for Poseida Therapeutics, Inc. (PSTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poseida Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Poseida Therapeutics, Inc. (PSTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Poseida Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Poseida Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Poseida Therapeutics, Inc. (PSTX)?

What is the highest PE Ratio for Poseida Therapeutics, Inc. (PSTX)?

What is the 3-year average PE Ratio for Poseida Therapeutics, Inc. (PSTX)?

What is the 5-year average PE Ratio for Poseida Therapeutics, Inc. (PSTX)?

How does the current PE Ratio for Poseida Therapeutics, Inc. (PSTX) compare to its historical average?